A Special Interest Group (SIG) of the Peripheral Nerve Society
Goals of the NPC
- To foster interactions among basic scientists, physician-scientists, translational-researchers, and clinicians to help identify novel pain therapies and translate basic science findings to clinics to help patients suffering from painful neuropathies and related disorders.
- To promote clinical and basic science research to elucidate the pathophysiology of pain and to facilitate and support high- quality clinical trials to develop effective preventative and therapeutic approaches.
- To promote collaborative interactions between basic, translational and clinical scientists and clinicians to develop guidelines, outcome measures and collaboration with stakeholder organizations.
- To promote standards of care and quality of care internationally.
- To develop guidelines, outcome measures, and clinical trials both independently and in collaboration with other stakeholder organizations.
- To work with patient advocacy and support/stakeholder organizations in the pursuit of the NPC’s mission and goals
- To support basic and clinical research, education, and standards of care in cooperation with patients and those developing treatments.
- To promote scientific and clinical education for basic translational and clinical scientists, clinicians, and other health professionals in neuropathic pain.
- To train basic scientists, clinician scientists and clinicians, and other health professionals in painful peripheral neuropathy and related disorders.
- To foster education and career development of trainees interested in pain basic and clinical research.
- To create opportunities for the dissemination of high-quality pain science in special events, such as annual meetings, and activities, in-person and using virtual formats, throughout the year in a format that facilitates networking between members and involves greater trainee participation
- To provide continuing education for those practicing and to encourage the interaction between basic scientists and clinicians for the benefit of patients.